Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation
Servier
Servier
Taproot Health
TopAlliance Biosciences
Emerald Clinical Inc.
Celgene
AEterna Zentaris
Novartis
Celldex Therapeutics
Valerio Therapeutics
Valerio Therapeutics
INSYS Therapeutics Inc
Infinity Pharmaceuticals, Inc.